These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 18031327

  • 1. Induction of hepatic 11beta-hydroxysteroid dehydrogenase type 1 in patients with alcoholic liver disease.
    Ahmed A, Saksena S, Sherlock M, Olliff SP, Elias E, Stewart PM.
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):898-903. PubMed ID: 18031327
    [Abstract] [Full Text] [Related]

  • 2. 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease.
    Stewart PM, Burra P, Shackleton CH, Sheppard MC, Elias E.
    J Clin Endocrinol Metab; 1993 Mar; 76(3):748-51. PubMed ID: 8445034
    [Abstract] [Full Text] [Related]

  • 3. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
    Konopelska S, Kienitz T, Hughes B, Pirlich M, Bauditz J, Lochs H, Strasburger CJ, Stewart PM, Quinkler M.
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
    [Abstract] [Full Text] [Related]

  • 4. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
    Homma M, Tanaka A, Hino K, Takamura H, Hirano T, Oka K, Kanazawa M, Miwa T, Notoya Y, Niitsuma T, Hayashi T.
    Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
    [Abstract] [Full Text] [Related]

  • 5. 11beta-hydroxysteroid dehydrogenase activity in acromegalic patients with normal or impaired carbohydrate metabolism.
    Mondok A, Varga I, Glaz E, Szucs N, Tóth M, Patocs A, Beko G, Racz K.
    Steroids; 2009 Sep; 74(9):725-9. PubMed ID: 19540999
    [Abstract] [Full Text] [Related]

  • 6. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
    Paulsen SK, Pedersen SB, Fisker S, Richelsen B.
    Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
    [Abstract] [Full Text] [Related]

  • 7. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K, Kullmann V, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM, Toogood AA, Tomlinson JW.
    Horm Res; 2001 Oct; 56 Suppl 1():1-6. PubMed ID: 11786677
    [Abstract] [Full Text] [Related]

  • 9. 11Beta hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle.
    Jang C, Obeyesekere VR, Dilley RJ, Alford FP, Inder WJ.
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):800-5. PubMed ID: 17121533
    [Abstract] [Full Text] [Related]

  • 10. 11beta-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action.
    Draper N, Stewart PM.
    J Endocrinol; 2005 Aug; 186(2):251-71. PubMed ID: 16079253
    [Abstract] [Full Text] [Related]

  • 11. Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver.
    Quinkler M, Jussli J, Bähr V, Pfeiffer AF, Lepenies J, Diederich S.
    Horm Metab Res; 2007 Aug; 39(8):555-9. PubMed ID: 17712719
    [Abstract] [Full Text] [Related]

  • 12. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, Yoshida M, Kambayashi M, Hashimoto K.
    Mol Cell Endocrinol; 2008 Mar 26; 285(1-2):10-8. PubMed ID: 18313835
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor-alpha upregulates 11beta-hydroxysteroid dehydrogenase type 1 expression by CCAAT/enhancer binding protein-beta in HepG2 cells.
    Ignatova ID, Kostadinova RM, Goldring CE, Nawrocki AR, Frey FJ, Frey BM.
    Am J Physiol Endocrinol Metab; 2009 Feb 26; 296(2):E367-77. PubMed ID: 19088256
    [Abstract] [Full Text] [Related]

  • 14. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
    Paulsen SK, Nielsen MP, Richelsen B, Bruun JM, Flyvbjerg A, Pedersen SB.
    Obesity (Silver Spring); 2008 Apr 26; 16(4):731-5. PubMed ID: 18379559
    [Abstract] [Full Text] [Related]

  • 15. Role of glucocorticoid receptor and CCAAT/enhancer-binding protein alpha in the feed-forward induction of 11beta-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts.
    Yang Z, Guo C, Zhu P, Li W, Myatt L, Sun K.
    J Endocrinol; 2007 Nov 26; 195(2):241-53. PubMed ID: 17951535
    [Abstract] [Full Text] [Related]

  • 16. Expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children.
    Mericq V, Medina P, Bouwman C, Johnson MC, Godoy J, López T, Iñiguez G.
    Horm Res; 2009 Nov 26; 71(2):89-93. PubMed ID: 19129713
    [Abstract] [Full Text] [Related]

  • 17. A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease.
    Ahmed A, Rabbitt E, Brady T, Brown C, Guest P, Bujalska IJ, Doig C, Newsome PN, Hubscher S, Elias E, Adams DH, Tomlinson JW, Stewart PM.
    PLoS One; 2012 Nov 26; 7(2):e29531. PubMed ID: 22363403
    [Abstract] [Full Text] [Related]

  • 18. Quantitative real-time PCR for the measurement of 11beta-HSD1 and 11beta-HSD2 mRNA levels in tissues of healthy dogs.
    Sieber-Ruckstuhl NS, Meli ML, Boretti FS, Gönczi E, Lutz H, Reusch CE.
    Horm Metab Res; 2007 Aug 26; 39(8):548-54. PubMed ID: 17712718
    [Abstract] [Full Text] [Related]

  • 19. Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases.
    Stegk JP, Ebert B, Martin HJ, Maser E.
    Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):104-8. PubMed ID: 19022342
    [Abstract] [Full Text] [Related]

  • 20. Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice.
    Alberts P, Engblom L, Edling N, Forsgren M, Klingström G, Larsson C, Rönquist-Nii Y, Ohman B, Abrahmsén L.
    Diabetologia; 2002 Nov 25; 45(11):1528-32. PubMed ID: 12436336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.